Syncona Investor Relations Material
Latest events
H2 2025
Syncona
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Syncona Limited
Access all reports
Syncona Limited is a closed-ended investment company based in Guernsey, specializing in the life sciences sector. The company's operations focus on founding, building, and funding companies to create a diversified portfolio of 20-25 globally leading healthcare companies.Syncona invests in a range of life sciences companies, including those working in gene therapy, cell therapy, biologics, and small molecule fields. Syncona is headquartered in Saint Peter Port, Guernsey, and its shares are listed on the London Stock Exchange.
Key slides for Syncona Limited
H2 2025
Syncona Limited
H2 2025
Syncona Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SYNC
Country
🇬🇧 United Kingdom